Ocugen, Inc. cash flow to debt ratio of -171.87% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Ocugen, Inc.'s free cash flow has decreased 25.53% from $-45.53M last year to $-57.15M, signaling decreasing performance

Ocugen, Inc.'s debt to equity ratio is -5.31, signaling that the company spent its equity and risk bankruptcy.

Ocugen, Inc.'s debt to equity ratio is -5.31, signaling that the company spent its equity and risk bankruptcy.

Ocugen, Inc. has negative EBITDA, making leverage ratio unreliable

Ocugen, Inc.'s interest coverage ratio is -8.16, which means that the company struggles to meet interest obligations, signaling financial risk.

Ocugen, Inc.'s profit margin has decreased (34.00%) in the last year from -1.33K% to -1.79K%, signaling decreasing performance

Ocugen, Inc.'s short-term assets of $24.34M exceed its short-term liabilities of $23.04M

Ocugen, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Ocugen, Inc.'s return on equity of 1.69K%, is higher than 15.00%, indicating good performance

Ocugen, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Ocugen, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Ocugen, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Ocugen, Inc. has negative free cash flow, indicating cash burn

Ocugen, Inc.'s yearly earnings has decreased 25.52% since last year from $-54.05M to $-67.85M, signaling decreasing performance

Ocugen, Inc.'s yearly revenue has increased 8.83% since last year from $4.05M to $4.41M, signaling increasing performance

ROIC -92.68% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Ocugen, Inc.'s 3-year revenue CAGR of 21.05% is positive, indicating growing revenue over the past 3 years

Ocugen, Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Ocugen, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Ocugen, Inc. has insufficient data to evaluate this check.

Ocugen, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Ocugen, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Ocugen, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Ocugen, Inc. is overvalued relative to its fair value price of -3.95 based on Earnings Fair Value model

Ocugen, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Ocugen, Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails

Ocugen, Inc. has a price-to-sales ratio of 97.04x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue